organization

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

24 projects, page 1 of 5
  • project . 2020 - 2023
    Funder: EC Project Code: 101005111
    Overall Budget: 3,435,100 EURFunder Contribution: 3,435,100 EUR
    Open Access mandate for Publications
    Partners: MicroLIQUID (Spain), BMVg, GNA BIOSOLUTIONS GMBH, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

    The DECISION consortium is developing a new class of diagnostic platform that will transform the fight against pandemics. The low-cost, miniaturised, disposable molecular diagnostic platform will allow for patient testing virtually anywhere, within a few minutes, with l...

  • project . 2020 - 2022
    Funder: EC Project Code: 101003544
    Overall Budget: 2,547,150 EURFunder Contribution: 2,547,150 EUR
    Open Access mandate for Publications
    Partners: AMU, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, UB, ICN2

    The recent outbreak in China caused by the emerging nCoV virus is challenging the level of global readiness from governments, public organizations and community to face and manage both its social and health consequences. Once the emergence is recognized and identified, ...

  • project . 2015 - 2017
    Funder: EC Project Code: 115844
    Overall Budget: 2,260,100 EURFunder Contribution: 2,260,100 EUR
    Open Access mandate for Publications
    Partners: GNA BIOSOLUTIONS GMBH, EMERGENCY ONG ONLUS, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, MENDELOVA UNIVERZITA V BRNE

    There is an urgent need for fast and accurate diagnostic tests in the current Ebola crisis. The rapid diagnosis of EVD during early and late stage of infection is a decisive step for risk assessment and for guidance to physicians to take the necessary decisions to limit...

  • project . 2020 - 2021
    Funder: EC Project Code: 101005075
    Overall Budget: 1,819,960 EURFunder Contribution: 784,470 EUR
    Open Access mandate for Publications
    Partners: BIOGENE LTD, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, AMU, UNIVERSITA DI CORSICA PASQUALE PAOLI, BG Research Ltd

    This project focuses on rapid (40min), simple, Point-of-Need COVID-19 testing, e.g. surgery/home (via first responders)/transit points of entry. BG Research (BGR) has developed direct from crude sample detection of viral pathogens – the QuRapID-XF technology, removing r...

  • project . 2015 - 2017
    Funder: EC Project Code: 115848
    Overall Budget: 4,398,250 EURFunder Contribution: 1,162,620 EUR
    Open Access mandate for Publications
    Partners: Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, FIND, DH, BNI, Alere (Germany), ALTONA

    We are proposing to develop a molecular assay for the safe, rapid, specific and sensitive detection of Ebola Virus Infection in capillary (or venous) blood samples combining ALTONA’s Pan-filo screening IVD test with the existing Alere™ q point of care molecular diagnost...

24 projects, page 1 of 5
Any information missing or wrong?Report an Issue